Fsa Wealth Management LLC Sage Therapeutics, Inc. Transaction History
Fsa Wealth Management LLC
- $250 Million
- Q3 2024
A detailed history of Fsa Wealth Management LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Fsa Wealth Management LLC holds 35 shares of SAGE stock, worth $196. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35
Previous 35
-0.0%
Holding current value
$196
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SAGE
# of Institutions
198Shares Held
46.5MCall Options Held
402KPut Options Held
209K-
Vanguard Group Inc Valley Forge, PA5.76MShares$32.3 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.59MShares$31.4 Million0.64% of portfolio
-
Black Rock Inc. New York, NY5.22MShares$29.3 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.46MShares$25 Million0.54% of portfolio
-
State Street Corp Boston, MA2.93MShares$16.4 Million0.0% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $333M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...